Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete

Autoimmune diseases affect approximately 5% of the population, but much work remains to define the genetic risk factors and pathogenic mechanisms underlying these conditions. There is accumulating evidence that common genetic factors might predispose to multiple autoimmune disorders. Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are complex autoimmune disorders with multiple susceptibility genes. The functional R620W (C1858T) polymorphism of the protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene, a member of the PTPs that negatively regulate T-cell activation, has been recently associated with susceptibility to various autoimmune diseases. The aim of this study was to assess whether the C1858T polymorphism of PTPN22 also confers increased risk for SLE and RA in the genetically homogeneous population of Crete. It was found that the minor T allele of the PTPN22 C1858T SNP was more common in SLE patients than in control individuals (odds ratio [OR]-=-1.91, 95% confidence interval [CI]-=-1.11 to 3.9, p-=-0.017). No significant difference was observed in the frequency of this allele when RA patients were compared with controls (OR-=-1.14, 95% CI-=-0.65 to 1.9, p-=-0.64). Although the PTPN22 1858-T allele is found at decreased frequency in Southern Europe, including Crete, an association was found between this allele and SLE in the population studied.